Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	61.53	-6.02	-15.64
Graham Fair Price	-34.45	2.46	3.75
PEG	7.88	0.05	0.04
Price/Book	-69.88	-2.00	6.66
Price/Cash Flow	93.02	-1.04	-14.97
Prices/Earnings	84.97	-0.34	-2.29
Price/Sales	-89.52	1.36	12.97
Price/FCF	93.02	-1.04	-14.97
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-29.81	0.33	0.47
Operating Margin	28.70	-0.84	-1.17
ROA	-100.00	-0.14	0.00
ROE	-0.73	1.46	100.37
ROIC	-0.60	-0.21	65.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.48	0.05	-89.57
EPS QOQ	0.53	0.07	-86.07
FCF QOQ	0.58	-1.00	72.60
Revenue QOQ	-0.58	0.33	-42.32
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	127.67	100.00
Days Sales Outstanding (DSO)	0.00	36.88	100.00
Inventory Turnover	0.00	0.70	100.00
Debt/Capitalization	0.00	1.17	100.00
Quick Ratio	0.00	0.39	100.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.93	-0.43	-53.69
Cash	1.49	0.65	-56.32
Capex	0.00	0.00	0.00
Free Cash Flow	-0.41	-0.82	-99.82
Revenue	0.48	0.63	33.14
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.00	0.76	100.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.04	-4.39	-44.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating